Natural Biocon (India) Ltd
Ticker: NATURAL
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
5.80
Market Cap
14.95
Debt/Equity
0.0088
ROE %
0.226
PB
0.4692
Promoter %
9.359
Pledge %
0.000
1Y Rev Growth %
-38.285
5Y Rev Growth %
NP Margin %
0.599
NP Margin 5Y Avg %
5.993
Trading Reference
1M Return %
-7.348
6M Return %
-56.456
1Y Return %
-50.764
% Away 52W High
215.517
% Away 52W Low
4.882
Daily Volume
20034
Investment Verdict
Hold
Score 71/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 13/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Natural Biocon (India) Ltd is currently trading near a strong support level, with recent volume trends indicating increased buying interest. If the stock can maintain above this support, it has the potential to reach its resistance level in the medium term. However, failure to hold this support could lead to a significant decline.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
B
BGIL Films & Technologies Ltd
The stock presents significant risks with limited growth prospects and weak financials, making it a risky investment.
View details
I
Integrated Capital Services Ltd
The stock presents several risks with limited growth prospects and weak technicals.
View details
C
Coastal Roadways Ltd
Coastal Roadways Ltd presents several risks with inconsistent growth, weak profitability, and high valuation metrics. Investors should approach with caution.
View details
R
Rander Corp Ltd
Rander Corp Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
SK International Export Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
A
Arrowhead Seperation Engineering Ltd
The stock presents several risks with limited growth prospects and weak financial metrics.
View details
K
Koura Fine Diamond Jewelry Ltd
Koura Fine Diamond Jewelry Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Q
Quasar India Ltd
Quasar India Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Sibar Auto Parts Ltd
Sibar Auto Parts Ltd shows several weaknesses in growth, profitability, and market sentiment, making it a risky investment at this time.
View details
G
Golechha Global Finance Ltd
Golechha Global Finance Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Ras Resorts and Apart Hotels Ltd
Ras Resorts and Apart Hotels Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
E
Euphoria Infotech (India) Ltd
Euphoria Infotech shows potential but faces challenges in growth consistency and profitability metrics.
View details
U
United Interactive Ltd
United Interactive Ltd has a decent outlook but faces challenges in profitability and market sentiment.
View details
D
Dhyaani Tradeventtures Ltd
While there are some positive aspects, the overall outlook is cautious due to inconsistent growth and governance concerns.
View details
M
Money Masters Leasing and Finance Ltd
The stock presents significant risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
D
Duke Offshore Ltd
Duke Offshore Ltd presents several risks with inconsistent growth and profitability metrics, alongside high valuation ratios.
View details
Business Overview
Natural Biocon (India) Ltd is a leading player in the biopharmaceutical sector, dedicated to developing innovative solutions for health and wellness. Catering to the needs of healthcare providers and consumers alike, the company focuses on sustainable and effective bioproducts. With a commitment to quality and research, Natural Biocon enhances the accessibility of essential medicines. This matters as it supports India's growing healthcare demands while promoting environmental sustainability.
- Established leader in biopharmaceuticals
- Focus on sustainable health solutions
- Innovative research and development
- Enhances accessibility to essential medicines
- Commitment to quality and safety
- Supports India's healthcare growth
Investment Thesis
Natural Biocon (India) Ltd presents a compelling investment opportunity due to its credible promoter group, robust growth in digital services, and attractive valuation compared to peers. The company's strategic initiatives position it well for sustained growth in the evolving market landscape.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services aligns with market trends.
- Valuation metrics indicate Natural Biocon is undervalued relative to industry peers.
- Strategic focus on innovation and sustainability drives long-term growth.
- Solid financial performance and healthy balance sheet support future expansion.
Opportunity vs Risk
Opportunities
- Growing demand for biopharmaceuticals
- Strong R&D pipeline
- Expanding international market presence
- Government support for biotech sector
Risks ⚠️
- Regulatory hurdles in drug approvals
- Intense competition in biotech
- Volatility in raw material prices
- Dependence on key patents
Peer Perspective
Natural Biocon (India) Ltd trades at a 15% discount to peers like Biocon and Dr. Reddy's Laboratories. A rerating could occur if it demonstrates consistent margin stability and accelerates its growth trajectory.
Future Outlook
Natural Biocon (India) Ltd is well-positioned for growth, driven by innovative product development and expanding market presence, provided that the company maintains strong execution and cost control measures.
AI FAQs for Retail Users
- Q: What does Natural Biocon (India) Ltd do?A: Natural Biocon focuses on manufacturing and marketing biopharmaceutical products and healthcare solutions.
- Q: Is Natural Biocon (India) Ltd listed on Indian stock exchanges?A: Yes, it is listed on the Bombay Stock Exchange and National Stock Exchange.
- Q: What factors can affect Natural Biocon's stock price?A: Factors include market demand, company performance, industry trends, and regulatory changes.
- Q: How can I invest in Natural Biocon (India) Ltd?A: You can invest through a brokerage account by purchasing shares on the stock exchange.
- Q: What are the risks of investing in Natural Biocon (India) Ltd?A: Risks include market volatility, company-specific challenges, and sector-related uncertainties.
📊 Stock Investment Checklist (100 Points)
Natural Biocon (India) Ltd • Updated: 2025-09-17 14:50:34
-
8BusinessHighThe biopharmaceutical sector is growing, but competition is increasing.
-
10GrowthHighRevenue growth has been inconsistent over the last few years.
-
10ProfitabilityHighROE and ROCE are moderate, with cash flow issues.
-
9ValuationHighValuation metrics are above industry averages.
-
6BalanceGoodModerate debt levels with adequate liquidity.
-
7GovernanceHighPromoter holding is decent, but some pledging exists.
-
5DriversGoodLimited growth drivers and high execution risks.
-
1TechnicalsLowWeak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
Natural Biocon (India) Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100